Schedule of restatement on the financial statements |
|
|
As
Previously Reported |
|
|
Adjustments |
|
|
As
Restated |
|
Balance
sheet as of December 31, 2020 (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
Warrant
Liabilities |
|
$ |
— |
|
|
$ |
31,375,000 |
|
|
$ |
31,375,000 |
|
Ordinary
Shares Subject to Possible Redemption |
|
|
197,029,190 |
|
|
|
(31,375,000 |
) |
|
|
165,654,190 |
|
Ordinary
Shares |
|
|
530 |
|
|
|
313 |
|
|
|
843 |
|
Additional
Paid-in Capital |
|
|
4,716,058 |
|
|
|
18,924,687 |
|
|
|
23,640,745 |
|
Retained
Earnings (Accumulated Deficit) |
|
|
283,420 |
|
|
|
(18,925,000 |
) |
|
|
(18,641,580 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement
of Operations for the Three Months Ended December 31, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
Change
in fair value of warrant liabilities |
|
$ |
— |
|
|
$ |
(5,875,000 |
) |
|
$ |
(5,875,000 |
) |
Net
loss |
|
|
(201,872 |
) |
|
|
(5,875,000 |
) |
|
|
(6,076,872 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
Flow Statement for the Period from February 14, 2020 (inception) to December 31, 2020 (audited) |
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss |
|
$ |
(201,872 |
) |
|
$ |
(5,875,000 |
) |
|
$ |
(6,076,872 |
) |
Change
in fair value of warrant liabilities |
|
|
— |
|
|
|
5,875,000 |
|
|
|
5,875,000 |
|
Change
in value of ordinary shares subject to possible redemption |
|
|
(201,870 |
) |
|
|
(5,875,000 |
) |
|
|
(6,076,870 |
) |
|